Maggi G, Casadio C, Cianci R, Molinatti M, Filosso P L, Nicolosi M, Oliaro A
Departement of Thoracic Surgery, University of Turin, Italy.
Int Surg. 1993 Jul-Sep;78(3):213-7.
Out of a series of 1563 consecutive patients submitted to thoracotomy for lung cancer between 1980 and 1990, 278 patients underwent a resection for a non small cell lung cancer (NSCLC) with mediastinal node metastases (N2). Selection of cases for surgery was carried out using CT from 1983 and mediastinoscopy for the patients with mediastinal lymph nodes larger than 1.5 cm from 1985: all patients with positive mediastinoscopy were excluded from thoracotomy, but 10 cases underwent a resection after neoadjuvant radio-chemotherapy. The surgical procedures were pneumonectomy (106), lobectomy (146) and atypical resection (8) with ipsilateral mediastinal lymphadenectomy. Resection was complete in 236 patients (84.8%) and incomplete in 42 patients (15.2%). Postoperative mortality was 3.2%. Almost all patients received radiotherapy after surgery. Actuarial 5-year survival was 13.7% for the entire group and 18.5% for the patients who underwent curative resection; no patients survived 5 years after palliative resection (p < 0.05). There were no differences with regard to prognosis according to the histology of the tumors and to surgical procedures. A better prognosis is associated with: completeness of resection, involvement of only one level, low T classification. Five-year survival rate of patients with metastases only in upper mediastinum was 25%; on the contrary 5-year survival rate of patients with metastases in the lymph nodes of the lower mediastinum was only 8% (p < 0.05). In our opinion better results among the patients with metastases in the upper mediastinum depends on the selection obtained with mediastinoscopy.(ABSTRACT TRUNCATED AT 250 WORDS)
在1980年至1990年间因肺癌接受开胸手术的1563例连续患者中,278例患者因非小细胞肺癌(NSCLC)伴纵隔淋巴结转移(N2)而接受了切除术。自1983年起使用CT进行手术病例选择,自1985年起对纵隔淋巴结大于1.5 cm的患者进行纵隔镜检查:所有纵隔镜检查阳性的患者均被排除在开胸手术之外,但有10例患者在新辅助放化疗后接受了切除术。手术方式包括全肺切除术(106例)、肺叶切除术(146例)和非典型切除术(8例),均行同侧纵隔淋巴结清扫术。236例患者(84.8%)切除完整,42例患者(15.2%)切除不完整。术后死亡率为3.2%。几乎所有患者术后均接受了放疗。整个组的5年精算生存率为13.7%,接受根治性切除术的患者为18.5%;姑息性切除术后无患者存活5年(p<0.05)。根据肿瘤组织学和手术方式,预后无差异。较好的预后与以下因素相关:切除的完整性、仅累及一个层面、低T分级。仅上纵隔有转移的患者5年生存率为25%;相反,下纵隔淋巴结有转移的患者5年生存率仅为8%(p<0.05)。我们认为,上纵隔有转移的患者中较好的结果取决于通过纵隔镜检查进行的病例选择。(摘要截短至250字)